(Q46182956)

20 December 2017

title

Synthesis and preliminary pharmacological evaluation of some cytisine derivatives (English)

1 reference

20 December 2017

1 reference

Canu Boido C

1

1 reference

20 December 2017

Sparatore F

series ordinal

2

1 reference

20 December 2017

publication date

1 July 1999

1 reference

20 December 2017

published in

Il Farmaco

1 reference

20 December 2017

volume

54

1 reference

20 December 2017

issue

7

1 reference

20 December 2017

page(s)

438-451

1 reference

20 December 2017

Some studies on cytisine and its methylated derivatives

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Brain nicotine binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Effects of lobeline, a nicotinic receptor agonist, on learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)-lobeline in the rat brainstem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

[N-aryl-thiocarbamyl-cytisine-derivatives. 1. Cytisine]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

The ensemble approach to distance geometry: application to the nicotinic pharmacophore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Bridged gamma-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Haloperidol-based irreversible inhibitors of the HIV-1 and HIV-2 proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Synthesis and pharmacology of Alkanediguanidinium compounds that block the neuronal nicotinic acetylcholine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Analogs of sparteine. 5. Antiarrhythmic activity of selected N,N'-disubstituted bispidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

alpha 2-Adrenergic agonist and antagonist activity of the respective (-)-and (+)-enantiomers of 6-ethyl-9-oxaergoline (EOE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

Vasodilator and inotropic effects of the antiarrhythmic drug melperone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2899%2900049-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-827X(99)00049-X

1 reference

20 December 2017

1 reference

20 December 2017